Johnson & Johnson has announced the termination of its experimental depression drug trials due to insufficient efficacy, a significant setback in mental health treatment research.
About the Author
Johnson & Johnson has announced the termination of its experimental depression drug trials due to insufficient efficacy, a significant setback in mental health treatment research.
